← Leaderboards
Joseph F Cotten
Massachusetts General Hospital
$6,246,440
Attributed
$6,430,623
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $840.6K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,430,623 · 7
By mechanism
R01$3,660,857 · 2
R21$1,644,273 · 3
K08$757,126 · 1
R41$368,367 · 1
Top collaborators
- Anthony Schwartz1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Fumito Ichinose$9,083,343
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBreathingResistanceMutantPotassium ChannelRegulationPharmacologyPotassiumResponseMediatingRattusMammalian CellElectrophysiology (Science)DoseProteinsAnestheticsOpioidBaseMolecularIn VivoVentilatory DepressionConsciousLeadAnesthesia Procedures
Grant awards (24)
Investigating the safety and efficacy of pillararene sulfates as novel and effective reversal agents for both steroidal and non-steroidal neuromuscular blocking agents.$368,367
R41 · FY2025 · GM
Xylazine and fentanyl effects on rat breathing, metabolism, and thermoregulation$208,174
R21 · FY2025 · DA · contact PI
Airway compromise and skeletal muscle rigidity as toxicity contributors in synthetic opioid and methamphetamine co-administered rats$207,712
R21 · FY2025 · DA · contact PI
Airway compromise and skeletal muscle rigidity as toxicity contributors in synthetic opioid and methamphetamine co-administered rats$244,891
R21 · FY2024 · DA · contact PI
Xylazine and fentanyl effects on rat breathing, metabolism, and thermoregulation$230,521
R21 · FY2024 · DA · contact PI
Anesthetic activation of TASK-3 tandem pore potassium channels: molecular mechanisms and behavioral effects$362,515
R01 · FY2021 · GM · contact PI
Anesthetic activation of TASK-3 tandem pore potassium channels: molecular mechanisms and behavioral effects$362,515
R01 · FY2020 · GM · contact PI
Anesthetic activation of TASK-3 tandem pore potassium channels: molecular mechanisms and behavioral effects$362,515
R01 · FY2019 · GM · contact PI
Safer, Non-addicting Pain Management: Identification and Expression of Cyclic Peptides with Analgesic and Breathing Stimulant Properties$252,750
R21 · FY2019 · DA · contact PI
Safer, Non-addicting Pain Management: Identification and Expression of Cyclic Peptides with Analgesic and Breathing Stimulant Properties$124,000
R21 · FY2019 · DA · contact PI
Anesthetic activation of TASK-3 tandem pore potassium channels: molecular mechanisms and behavioral effects$464,416
R01 · FY2018 · GM · contact PI
Safer, Non-addicting Pain Management: Identification and Expression of Cyclic Peptides with Analgesic and Breathing Stimulant Properties$210,625
R21 · FY2018 · DA · contact PI
Safer, Non-addicting Pain Management: Identification and Expression of Cyclic Peptides with Analgesic and Breathing Stimulant Properties$165,600
R21 · FY2018 · DA · contact PI
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing$433,695
R01 · FY2017 · HL · contact PI
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing$433,695
R01 · FY2016 · HL · contact PI
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing$427,189
R01 · FY2015 · HL · contact PI
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing$425,021
R01 · FY2014 · HL · contact PI
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing$389,296
R01 · FY2013 · HL · contact PI
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels$125,414
K08 · FY2012 · GM · contact PI
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels$130,927
K08 · FY2011 · GM · contact PI
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels$130,928
K08 · FY2010 · GM · contact PI
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels$130,928
K08 · FY2009 · GM · contact PI
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels$108,000
K08 · FY2009 · GM · contact PI
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels$130,929
K08 · FY2008 · GM · contact PI